Universal Bioenergy Reports Record Sales of $13.96 Million for Q2

IRVINE, Calif., Sept. 8 /PRNewswire-FirstCall/ -- Universal Bioenergy, (OTC Bulletin Board/Pink Sheets: UBRG), reported record sales of $13.96 million for the second quarter ending June 30, 2010. The Company reported its full financial results in its recent second quarter Form 10Q filing with the SEC.

Universal's total assets increased by 976%, to $2.88 million for the period ending  June 30, 2010, from $295,919 for the year ending  December 31 of 2009. The estimated book value per share based on the Company's assets of $2.88 million is $0.064 per share.  The Company's net loss was reduced by 26.71%, to a net loss $460,213 for the period ending June 30, 2010, from $627,966 for the period ending June 30, 2009.  The Company attributes the net loss to its corporate restructuring, product financing costs, and  one time charges for  the acquisition of NDR Energy Group LLC.

Universal's SR. Vice President Solomon Ali states, "We are very pleased with our strong financial performance this quarter, despite this recession. This is a major milestone for the Company.  Our current management, in its pursuit to build a strong, stable company, generated  sales  of $13.9 million, and added significant value to the Company. This is especially significant, since the Company produced no revenues in the prior 2 to 3 years. We're very bullish about our plans for growth and expansion, through mergers and acquisitions, and introducing new green technology products. We believe we will continue the trend to increase our revenues, reduce our losses, and then move our company toward solid profitability."

About  The Company

Universal Bioenergy, Inc. is an alternative energy company, and intends to create and market natural and alternative energy sources including natural gas, solar, biofuels, wind, synthetic fuels and related energy technology products. It plans to build the company into a prominent player in alternative energy.

Safe Harbor Statement - There are matters discussed in this media information that are forward looking statements within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. Such statements are only forecasts and actual events or results may differ materially from those discussed. For a discussion of important factors which could cause actual results to differ from the forward looking statements, refer to Universal Bioenergy Inc.'s most recent annual report and accounts and other SEC filings. The company undertakes no obligation to update publicly, or revise, forward looking  statements, whether as a result of new information, future events or otherwise, except to the extent legally required.

SOURCE Universal Bioenergy, Inc.